Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04684108
Title SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
The First Affiliated Hospital of Bengbu Medical College Bengbu Anhui 233099 China Details
Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing Beijing 100020 China Details
Beijing Jishuitan Hostipal Beijing Beijing 100032 China Details
Shenzhen Second People's Hospital Shenzhen Guangzhou 518025 China Details
The Fourth Affiliated Hospital of Hebei Medical University Shijiazhuang Hebei 050011 China Details
Henan Cancer Hospital Zhengzhou Henan 450003 China Details
Wuhan University Central South Hospital Wuhan Hubei 430062 China Details
Xiangyang Central Hospital Xiangyang Hubei 441021 China Details
Wuxi Central Hospital Wuxi Jiangsu 214125 China Details
The First Affiliated Hospital of China Medical University Shenyang Liaoning 110002 China Details
Shengjing Hospital Affiliated to China Medical University Shenyang Liaoning 110136 China Details
Qilu Hospital of Shandong University Jinan Shandong 250063 China Details
Shanxi Norman Bethune Hospital Taiyuan Shanxi 030032 China Details
The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field